Stephens Investment Management Group’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-105,504
Closed -$4.45M 177
2023
Q2
$4.45M Buy
105,504
+2,780
+3% +$112K 0.07% 147
2023
Q1
$3.66M Buy
102,724
+50
+0% +$1.81K 0.06% 146
2022
Q4
$3.79M Sell
102,674
-25,967
-20% -$1.03M 0.07% 145
2022
Q3
$6.07M Sell
128,641
-2,261
-2% -$146K 0.12% 140
2022
Q2
$9.38M Hold
130,902
0.17% 125
2022
Q1
$10.6M Buy
130,902
+96
+0.1% +$8.12K 0.16% 127
2021
Q4
$13.4M Sell
130,806
-257
-0.2% -$24.7K 0.17% 131
2021
Q3
$11.5M Buy
+131,063
New +$11.9M 0.16% 136

Other funds holding SYNH

Stephens Investment Management Group's SYNH Position: Q3 2023 in Review

Stephens Investment Management Group sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 105,504 shares — an estimated $4.45M sold.

Stephens Investment Management Group first reported a position in SYNH in Q3 2021 and held it in 8 quarters. The position peaked at $13.4M in Q4 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Stephens Investment Management Group reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Stephens Investment Management Group sold 105,504 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $4.45M.
  • Stephens Investment Management Group first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2021 and held it in 8 quarters.
  • Stephens Investment Management Group's Syneos Health, Inc. Class A Common Stock position peaked at $13.4M in Q4 2021.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Stephens Investment Management Group's 13F filing for Q3 2023, filed 14 Nov 2023.